Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ziad Omran

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Bioorganic & Medicinal Chemistry Letters|March 21, 2021
Development of new disulfiram analogues as ALDH1a1-selective inhibitorsZiad Omran
Molecules (Basel, Switzerland)|January 21, 2022
Novel Disulfiram Derivatives as ALDH1a1-Selective InhibitorsZiad Omran
Molecules (Basel, Switzerland)|June 2, 2021
New Disulfiram Derivatives as MAGL-Selective InhibitorsZiad Omran
Mini Reviews in Medicinal Chemistry|June 21, 2016
Obesity: Current Treatment and Future HorizonsZiad Omran
Pharmaceuticals (Basel, Switzerland)|February 27, 2026
Disulfiram and Its Derivatives: An Immortal Phoenix of Drug RepurposingZiad Omran, Omeima Abdullah
European Biophysics Journal : EBJ|April 2, 2014
Acid-mediated Lipinski's second rule: application to drug design and targeting in cancerZiad Omran, Cyril Rauch
International Journal of Molecular Sciences|October 26, 2024
Geldanamycins: Potent Hsp90 Inhibitors with Significant Potential in Cancer TherapyOmeima Abdullah, Ziad Omran
Journal of Enzyme Inhibition and Medicinal Chemistry|November 27, 2007
Synthesis of new bisaryl cyclopentathiophene and thienocyclopentoxazolidine derivatives as potential cytotoxic agentsZiad Omran, Patrick Dallemagne, Sylvain Rault
Biological & Pharmaceutical Bulletin|November 6, 2024
Anticancer Effects of New Disulfiram AnalogsOmeima Abdullah, Christopher A Beaudoin, Ziad Omran
Seminars in Cancer Biology|January 13, 2017
Physical and biological characteristics of multi drug resistance (MDR): An integral approach considering pH and drug resistance in cancerZiad Omran, Paula Scaife, Simon Stewart, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Bioorganic & Medicinal Chemistry Letters|March 21, 2021
Development of new disulfiram analogues as ALDH1a1-selective inhibitorsZiad Omran
Molecules (Basel, Switzerland)|January 21, 2022
Novel Disulfiram Derivatives as ALDH1a1-Selective InhibitorsZiad Omran
Molecules (Basel, Switzerland)|June 2, 2021
New Disulfiram Derivatives as MAGL-Selective InhibitorsZiad Omran
Mini Reviews in Medicinal Chemistry|June 21, 2016
Obesity: Current Treatment and Future HorizonsZiad Omran
Pharmaceuticals (Basel, Switzerland)|February 27, 2026
Disulfiram and Its Derivatives: An Immortal Phoenix of Drug RepurposingZiad Omran, Omeima Abdullah
European Biophysics Journal : EBJ|April 2, 2014
Acid-mediated Lipinski's second rule: application to drug design and targeting in cancerZiad Omran, Cyril Rauch
International Journal of Molecular Sciences|October 26, 2024
Geldanamycins: Potent Hsp90 Inhibitors with Significant Potential in Cancer TherapyOmeima Abdullah, Ziad Omran
Journal of Enzyme Inhibition and Medicinal Chemistry|November 27, 2007
Synthesis of new bisaryl cyclopentathiophene and thienocyclopentoxazolidine derivatives as potential cytotoxic agentsZiad Omran, Patrick Dallemagne, Sylvain Rault
Biological & Pharmaceutical Bulletin|November 6, 2024
Anticancer Effects of New Disulfiram AnalogsOmeima Abdullah, Christopher A Beaudoin, Ziad Omran
Seminars in Cancer Biology|January 13, 2017
Physical and biological characteristics of multi drug resistance (MDR): An integral approach considering pH and drug resistance in cancerZiad Omran, Paula Scaife, Simon Stewart, et al.
Pageof 5